Status:
COMPLETED
Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
Laval University
Collaborating Sponsors:
McGill University
Boehringer Ingelheim
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This study was designed to test the following hypothesis: The 3-min constant rate step test and the 3-min constant rate shuttle walk test will be sensitive to detect improvement in exertional dyspnea...
Detailed Description
BACKGROUND: Cycle and/or treadmill exercise modalities may not adequately reflect the constraints of the physical activities of daily living and may not easily transfer to the primary care setting. Th...
Eligibility Criteria
Inclusion
- age \> 50 years
- smoking history \> 10 packs/year
- post-bronchodilator FEV1 between 30 and 80% predicted and FEV1/FVC \< 70% as assessed in previous pulmonary function test (GOLD stage II and III)
Exclusion
- respiratory exacerbation within the preceding 2 months
- history of asthma
- significant O2 desaturation (SaO2 \< 85%) at rest or during exercise
- presence of another pathology that could influence exercise tolerance
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00807534
Start Date
October 1 2008
End Date
June 1 2010
Last Update
February 9 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hélène Perrault
Montreal, Quebec, Canada
2
François Maltais
Québec, Quebec, Canada, G1V4G5